DAWN
NASDAQDay One Biopharmaceuticals Inc.
Price$21.52+0.02 (+0.12%)
01:30 PM08:00 PM
News · 26 weeks105+94%
2025-10-262026-04-19
Mix6490d
- SEC Filings24(38%)
- Insider22(34%)
- Other15(23%)
- Earnings2(3%)
- Analyst1(2%)
Latest news
25 items- INSIDERCHIEF EXECUTIVE OFFICER Bender Jeremy returned 1,799,031 shares to the company, closing all direct ownership in the company (SEC Form 4) (for withholding tax)4 - Day One Biopharmaceuticals, Inc. (0001845337) (Issuer)
- INSIDERHead of Research and Dev. Vasconcelles Michael returned 4,397 shares to the company, closing all direct ownership in the company (SEC Form 4) (withholding obligation)4 - Day One Biopharmaceuticals, Inc. (0001845337) (Issuer)
- INSIDERCOO and CFO York Charles N Ii returned 312,025 shares to the company, closing all direct ownership in the company (SEC Form 4) (tax withholding)4 - Day One Biopharmaceuticals, Inc. (0001845337) (Issuer)
- INSIDERGen Counsel & Secretary Dubow Adam returned 72,694 shares to the company, closing all direct ownership in the company (SEC Form 4) to cover taxes4 - Day One Biopharmaceuticals, Inc. (0001845337) (Issuer)
- INSIDERDirector Holles Natalie C. returned 57,310 shares to the company, closing all direct ownership in the company (SEC Form 4) to satisfy tax liability4 - Day One Biopharmaceuticals, Inc. (0001845337) (Issuer)
- INSIDERDirector Ramasastry Saira returned 40,485 shares to the company, closing all direct ownership in the company (SEC Form 4) to cover taxes4 - Day One Biopharmaceuticals, Inc. (0001845337) (Issuer)
- INSIDERDirector Josey John A. returned 72,292 shares to the company, closing all direct ownership in the company (SEC Form 4) (for withholding tax)4 - Day One Biopharmaceuticals, Inc. (0001845337) (Issuer)
- INSIDERSEC Form 4 filed by Director Garland J. Scott (withholding tax)4 - Day One Biopharmaceuticals, Inc. (0001845337) (Issuer)
- INSIDERSEC Form 4 filed by Director Dable Habib J to cover withholding tax4 - Day One Biopharmaceuticals, Inc. (0001845337) (Issuer)
- INSIDERSEC Form 4 filed by Director Grossman William to satisfy withholding tax4 - Day One Biopharmaceuticals, Inc. (0001845337) (Issuer)
- INSIDERSEC Form 4 filed by Director Nicholson Garry A to satisfy withholding tax4 - Day One Biopharmaceuticals, Inc. (0001845337) (Issuer)
- INSIDERChief Commercial Officer Merendino Lauren returned 60,157 shares to the company, closing all direct ownership in the company (SEC Form 4) (for tax liability)4 - Day One Biopharmaceuticals, Inc. (0001845337) (Issuer)
- SECSEC Form 25-NSE filed by Day One Biopharmaceuticals Inc.25-NSE - Day One Biopharmaceuticals, Inc. (0001845337) (Subject)
- SECSEC Form S-8 POS filed by Day One Biopharmaceuticals Inc.S-8 POS - Day One Biopharmaceuticals, Inc. (0001845337) (Filer)
- SECSEC Form S-8 POS filed by Day One Biopharmaceuticals Inc.S-8 POS - Day One Biopharmaceuticals, Inc. (0001845337) (Filer)
- SECSEC Form S-8 POS filed by Day One Biopharmaceuticals Inc.S-8 POS - Day One Biopharmaceuticals, Inc. (0001845337) (Filer)
- SECSEC Form S-8 POS filed by Day One Biopharmaceuticals Inc.S-8 POS - Day One Biopharmaceuticals, Inc. (0001845337) (Filer)
- SECSEC Form S-8 POS filed by Day One Biopharmaceuticals Inc.S-8 POS - Day One Biopharmaceuticals, Inc. (0001845337) (Filer)
- SECSEC Form S-8 POS filed by Day One Biopharmaceuticals Inc.S-8 POS - Day One Biopharmaceuticals, Inc. (0001845337) (Filer)
- SECSEC Form POSASR filed by Day One Biopharmaceuticals Inc.POSASR - Day One Biopharmaceuticals, Inc. (0001845337) (Filer)
- SECSEC Form POSASR filed by Day One Biopharmaceuticals Inc.POSASR - Day One Biopharmaceuticals, Inc. (0001845337) (Filer)
- SECDay One Biopharmaceuticals Inc. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Changes in Control of Registrant, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Completion of Acquisition or Disposition of Assets, Leadership Update8-K - Day One Biopharmaceuticals, Inc. (0001845337) (Filer)
- SECAmendment: SEC Form SC 14D9/A filed by Day One Biopharmaceuticals Inc.SC 14D9/A - Day One Biopharmaceuticals, Inc. (0001845337) (Subject)
- SECAmendment: SEC Form SC TO-T/A filed by Day One Biopharmaceuticals Inc.SC TO-T/A - Day One Biopharmaceuticals, Inc. (0001845337) (Subject)
- PRServier completes the acquisition of Day One BiopharmaceuticalsAcquisition expands Servier's position in oncology with tovorafenib marketed as OJEMDATM in the U.S. in pediatric low-grade glioma. Transaction also includes a strong oncology pipeline of clinical stage assets in rare cancers with high unmet needs. Transaction represents total equity value of approximately $2.5 billion.SURESNES, France, April 23, 2026 /CNW/ -- Servier, an independent international pharmaceutical group governed by a foundation, today announced the successful completion of the tender offer to acquire all of the issued and outstanding shares of common stock of Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN) ("Day One"), a biopharmaceutical company dedicated to developing and com